A blueprint for DNA vaccine design

Methods in Molecular Biology

Volumn 1143, Issue , 2014, Pages 3-10

  Iurescia, Sandra ^a   Fioretti, Daniela ^a   Rinaldi, Monica ^a  

^a NONE

Author keywords

Antigen; DNA uptake; DNA vaccines; Immunogenicity; Innate immunity; Marker selection; Plasmid design; Regulatory elements; Transgene expression

Indexed keywords

DNA VACCINE; PLASMID DNA; ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; DNA MODIFICATION; DNA SEQUENCE; DRUG DELIVERY DEVICE; DRUG DESIGN; DRUG SAFETY; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INNATE IMMUNITY; MATRIX ATTACHMENT REGION; NEXT GENERATION SEQUENCING; OUTCOME ASSESSMENT; PLASMID; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY; TRANSGENE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY;

ANTIGENS; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; PLASMIDS; TRANSGENES; VACCINES, DNA;

EID: 84904444274     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-0410-5_1     Document Type: Article

References (34)

1. Kutzler MA, Weiner DB (2008) DNA vaccines: ready for prime time? Nat Rev Genet 9: 776-788.
2. Fioretti D, Iurescia S, Rinaldi M (2013) Recent advances in design of immunogenic and effective naked DNA vaccines against cancer. Recent Pat Anticancer Drug Discov 9: 66-82.
3. Donnelly JJ, Ulmer JB, Shiver JW et al (1997) DNA vaccines. Annu Rev Immunol 15: 617-648.
4. Cheng L, Ziegelhoffer PR, Yang NS (1993) In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment. Proc Natl Acad Sci USA 90: 4455-4459.
5. Manthorpe M, Cornefert-Jensen F, Hartikka J et al (1993) Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice. Hum Gene Ther 4: 419-431.
6. Cazeaux N, Bennasser Y, Vidal PL et al (2002) Comparative study of immune responses induced after immunization with plasmids encoding the HIV-1 Nef protein under the control of the CMV-IE or the muscle-specific desmin promoter. Vaccine 20: 3322-3331.
7. Luke JM, Vincent JM, Du SX et al (2011) Improved antibiotic-free plasmid vector design by incorporation of transient expression enhancers. Gene Ther 18: 334-343.
8. Barouch DH, Yang ZY, Kong WP et al (2005) A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates. J Virol 79: 8828-8834.
9. Li C, Goudy K, Hirsch M et al (2009) Cellular immune response to cryptic epitopes during therapeutic gene transfer. Proc Natl Acad Sci USA 106: 10770-10774.
10. Williams JAV (2013) Vector design for improved DNA vaccine efficacy, safety and production. Vaccine 1: 225-249.
11. EMA (2007) Presence of the antibiotic resistance marker gene nptII in GM plants for food and feed uses. Vol EMEA/CVMP/56937/2007.
12. Oliveira PH, Mairhofer J (2013) Marker-free plasmids for biotechnological applications: implications and perspectives. Trends Biotechnol 31: 539-547.
13. Schleef M (2013) Minicircle and miniplasmid DNA vectors: the future of nonviral and viral gene transfer. Wiley, Weinheim.
14. Osborn MJ, McElmurry RT, Lees CJ et al (2011) Minicircle DNA-based gene therapy coupled with immune modulation permits long-term expression of alpha-L-iduronidase in mice with mucopolysaccharidosis type I. Mol Ther 19: 450-460.
15. Narsinh KH, Jia F, Robbins RC et al (2011) Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors. Nat Protoc 6: 78-88.
16. Andre S, Seed B, Eberle J et al (1998) Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage. J Virol 72: 1497-1503.
17. Fath S, Bauer AP, Liss M et al (2011) Multiparameter RNA and codon optimization: a standardized tool to assess and enhance autologous mammalian gene expression. PLoS One 6: e17596.
18. Weide B, Garbe C, Rammensee HG et al (2008) Plasmid DNA-and messenger RNAbased anti-cancer vaccination. Immunol Lett 115: 33-42.
19. Williams JA, Carnes AE, Hodgson CP (2009) Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production. Biotechnol Adv 27: 353-370.
20. Laddy DJ, Yan J, Kutzler M et al (2008) Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens. PLoS One 3: e2517.
21. Rinaldi M, Fioretti D, Iurescia S et al (2008) Anti-tumor immunity induced by CDR3-based DNA vaccination in a murine B-cell lymphoma model. Biochem Biophys Res Commun 370: 279-284.
22. Lam AP, Dean DA (2010) Progress and prospects: nuclear import of nonviral vectors. Gene Ther 17: 439-447.
23. Conese M, Auriche C, Ascenzioni F (2004) Gene therapy progress and prospects: episomally maintained self-replicating systems. Gene Ther 11: 1735-1741.
24. Argyros O, Wong SP, Fedonidis C et al (2011) Development of S/MAR minicircles for enhanced and persistent transgene expression in the mouse liver. J Mol Med (Berl) 89: 515-529.
25. Coban C, Koyama S, Takeshita F et al (2008) Molecular and cellular mechanisms of DNA vaccines. Hum Vaccin 4: 453-456.
26. Desmet CJ, Ishii KJ (2012) Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination. Nat Rev Immunol 12: 479-491.
27. O'Neill LA (2013) Immunology. Sensing the dark side of DNA. Science 339: 763-764.
28. Loo YM, Gale M Jr (2011) Immune signaling by RIG-I-like receptors. Immunity 34: 680-692.
29. Babiuk S, Mookherjee N, Pontarollo R et al (2004) TLR9-/-and TLR9+/+ mice display similar immune responses to a DNA vaccine. Immunology 113: 114-120.
30. Ishii KJ, Kawagoe T, Koyama S et al (2008) TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature 451: 725-729.
31. Kobiyama K, Jounai N, Aoshi T, Tozuka M, Takeshita F, Coban C, Ishii KJ (2013) Innate immune signaling by, and genetic adjuvants for DNA vaccination. Vaccine 1: 278-292.
32. Coban C, Kobiyama K, Aoshi T et al (2011) Novel strategies to improve DNA vaccine immunogenicity. Curr Gene Ther 11: 479-484.
33. Li L, Saade F, Petrovsky N (2012) The future of human DNA vaccines. J Biotechnol 162: 171-182.
34. Sandhu KS, Pandey S, Maiti S et al (2008) GASCO: genetic algorithm simulation for codon optimization. In Silico Biol 8: 187-192.